Ashmore Emerging Markets Sm Cp Eq A ESSAX

Medalist Rating as of | See Ashmore Investment Hub
  • NAV / 1-Day Return 14.62  /  +0.62 %
  • Total Assets 10.7 Mil
  • Adj. Expense Ratio
    1.520%
  • Expense Ratio 1.520%
  • Distribution Fee Level High
  • Share Class Type Front Load
  • Category Diversified Emerging Mkts
  • Investment Style Mid Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.56%
  • Turnover 79%

USD | NAV as of Sep 28, 2024 | 1-Day Return as of Sep 28, 2024, 12:17 AM GMT+0

Morningstar’s Analysis ESSAX

Will ESSAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Ashmore Emerging Markets Sm Cp Eq A earns a Morningstar Medalist Rating of Neutral with strength in areas such as Process offset by weaker spots such as People.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ESSAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 31.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

MY E.G.Services Bhd

5.43 575,180
Technology

WinWay Technology Co Ltd Ordinary Shares

3.95 418,904
Technology

E Ink Holdings Inc

3.68 389,920
Technology

Gudeng Precision Industrial Co Ltd

3.37 356,938
Technology

Dentium Co Ltd

3.09 327,998
Healthcare

Medi Assist Healthcare Services Ltd

2.67 283,520
Healthcare

Radico Khaitan Ltd

2.47 261,394
Consumer Defensive

Granules India Ltd

2.44 258,420
Healthcare

Eugene Technology Co Ltd

2.38 251,909
Technology

PB Fintech Ltd

2.29 242,643
Financial Services

Sponsor Center